IBDEI03Y ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4710,1,3,0)
 ;;=3^Dermatitis,Exfoliative
 ;;^UTILITY(U,$J,358.3,4710,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,4710,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,4711,0)
 ;;=L98.1^^22^294^9
 ;;^UTILITY(U,$J,358.3,4711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4711,1,3,0)
 ;;=3^Dermatitis,Factitial
 ;;^UTILITY(U,$J,358.3,4711,1,4,0)
 ;;=4^L98.1
 ;;^UTILITY(U,$J,358.3,4711,2)
 ;;=^186781
 ;;^UTILITY(U,$J,358.3,4712,0)
 ;;=L30.3^^22^294^11
 ;;^UTILITY(U,$J,358.3,4712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4712,1,3,0)
 ;;=3^Dermatitis,Infective
 ;;^UTILITY(U,$J,358.3,4712,1,4,0)
 ;;=4^L30.3
 ;;^UTILITY(U,$J,358.3,4712,2)
 ;;=^5009156
 ;;^UTILITY(U,$J,358.3,4713,0)
 ;;=L56.2^^22^294^19
 ;;^UTILITY(U,$J,358.3,4713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4713,1,3,0)
 ;;=3^Dermatitis,Photocontact
 ;;^UTILITY(U,$J,358.3,4713,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,4713,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,4714,0)
 ;;=L71.0^^22^294^18
 ;;^UTILITY(U,$J,358.3,4714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4714,1,3,0)
 ;;=3^Dermatitis,Perioral
 ;;^UTILITY(U,$J,358.3,4714,1,4,0)
 ;;=4^L71.0
 ;;^UTILITY(U,$J,358.3,4714,2)
 ;;=^5009274
 ;;^UTILITY(U,$J,358.3,4715,0)
 ;;=L23.1^^22^294^2
 ;;^UTILITY(U,$J,358.3,4715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4715,1,3,0)
 ;;=3^Dermatitis,Allergic Contact d/t Adhesives
 ;;^UTILITY(U,$J,358.3,4715,1,4,0)
 ;;=4^L23.1
 ;;^UTILITY(U,$J,358.3,4715,2)
 ;;=^5009116
 ;;^UTILITY(U,$J,358.3,4716,0)
 ;;=L23.81^^22^294^3
 ;;^UTILITY(U,$J,358.3,4716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4716,1,3,0)
 ;;=3^Dermatitis,Allergic Contact d/t Animal Dander
 ;;^UTILITY(U,$J,358.3,4716,1,4,0)
 ;;=4^L23.81
 ;;^UTILITY(U,$J,358.3,4716,2)
 ;;=^5009123
 ;;^UTILITY(U,$J,358.3,4717,0)
 ;;=L23.0^^22^294^5
 ;;^UTILITY(U,$J,358.3,4717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4717,1,3,0)
 ;;=3^Dermatitis,Allergic Contact d/t Metals
 ;;^UTILITY(U,$J,358.3,4717,1,4,0)
 ;;=4^L23.0
 ;;^UTILITY(U,$J,358.3,4717,2)
 ;;=^5009115
 ;;^UTILITY(U,$J,358.3,4718,0)
 ;;=B00.1^^22^294^10
 ;;^UTILITY(U,$J,358.3,4718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4718,1,3,0)
 ;;=3^Dermatitis,Herpes Simplex
 ;;^UTILITY(U,$J,358.3,4718,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,4718,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,4719,0)
 ;;=L24.0^^22^294^13
 ;;^UTILITY(U,$J,358.3,4719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4719,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Detergents
 ;;^UTILITY(U,$J,358.3,4719,1,4,0)
 ;;=4^L24.0
 ;;^UTILITY(U,$J,358.3,4719,2)
 ;;=^5009126
 ;;^UTILITY(U,$J,358.3,4720,0)
 ;;=L24.81^^22^294^14
 ;;^UTILITY(U,$J,358.3,4720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4720,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Metals
 ;;^UTILITY(U,$J,358.3,4720,1,4,0)
 ;;=4^L24.81
 ;;^UTILITY(U,$J,358.3,4720,2)
 ;;=^5009134
 ;;^UTILITY(U,$J,358.3,4721,0)
 ;;=L24.2^^22^294^15
 ;;^UTILITY(U,$J,358.3,4721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4721,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Solvents
 ;;^UTILITY(U,$J,358.3,4721,1,4,0)
 ;;=4^L24.2
 ;;^UTILITY(U,$J,358.3,4721,2)
 ;;=^5009128
 ;;^UTILITY(U,$J,358.3,4722,0)
 ;;=E08.620^^22^294^22
 ;;^UTILITY(U,$J,358.3,4722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4722,1,3,0)
 ;;=3^Diabetes d/t Underlying Condition w/ DM Dermatitis
 ;;^UTILITY(U,$J,358.3,4722,1,4,0)
 ;;=4^E08.620
 ;;^UTILITY(U,$J,358.3,4722,2)
 ;;=^5002533
 ;;^UTILITY(U,$J,358.3,4723,0)
 ;;=E08.621^^22^294^24
 ;;^UTILITY(U,$J,358.3,4723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4723,1,3,0)
 ;;=3^Diabetes d/t Underlying Conditions w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,4723,1,4,0)
 ;;=4^E08.621
 ;;^UTILITY(U,$J,358.3,4723,2)
 ;;=^5002534
 ;;^UTILITY(U,$J,358.3,4724,0)
 ;;=T81.33XA^^22^294^27
 ;;^UTILITY(U,$J,358.3,4724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4724,1,3,0)
 ;;=3^Disruption Traumatic Inj/Wound Repair,Init Encntr
 ;;^UTILITY(U,$J,358.3,4724,1,4,0)
 ;;=4^T81.33XA
 ;;^UTILITY(U,$J,358.3,4724,2)
 ;;=^5054476
 ;;^UTILITY(U,$J,358.3,4725,0)
 ;;=L60.3^^22^294^30
 ;;^UTILITY(U,$J,358.3,4725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4725,1,3,0)
 ;;=3^Dystrophic Nails
 ;;^UTILITY(U,$J,358.3,4725,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,4725,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,4726,0)
 ;;=M71.30^^22^294^25
 ;;^UTILITY(U,$J,358.3,4726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4726,1,3,0)
 ;;=3^Digital Mucous Cyst
 ;;^UTILITY(U,$J,358.3,4726,1,4,0)
 ;;=4^M71.30
 ;;^UTILITY(U,$J,358.3,4726,2)
 ;;=^5013149
 ;;^UTILITY(U,$J,358.3,4727,0)
 ;;=L30.4^^22^295^9
 ;;^UTILITY(U,$J,358.3,4727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4727,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,4727,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,4727,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,4728,0)
 ;;=R60.0^^22^295^6
 ;;^UTILITY(U,$J,358.3,4728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4728,1,3,0)
 ;;=3^Edema,Localized
 ;;^UTILITY(U,$J,358.3,4728,1,4,0)
 ;;=4^R60.0
 ;;^UTILITY(U,$J,358.3,4728,2)
 ;;=^5019532
 ;;^UTILITY(U,$J,358.3,4729,0)
 ;;=L53.0^^22^295^13
 ;;^UTILITY(U,$J,358.3,4729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4729,1,3,0)
 ;;=3^Erythema Toxic
 ;;^UTILITY(U,$J,358.3,4729,1,4,0)
 ;;=4^L53.0
 ;;^UTILITY(U,$J,358.3,4729,2)
 ;;=^5009207
 ;;^UTILITY(U,$J,358.3,4730,0)
 ;;=L53.1^^22^295^8
 ;;^UTILITY(U,$J,358.3,4730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4730,1,3,0)
 ;;=3^Erythema Annulare Centrifugum
 ;;^UTILITY(U,$J,358.3,4730,1,4,0)
 ;;=4^L53.1
 ;;^UTILITY(U,$J,358.3,4730,2)
 ;;=^5009208
 ;;^UTILITY(U,$J,358.3,4731,0)
 ;;=L51.9^^22^295^11
 ;;^UTILITY(U,$J,358.3,4731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4731,1,3,0)
 ;;=3^Erythema Multiforme,Unspec
 ;;^UTILITY(U,$J,358.3,4731,1,4,0)
 ;;=4^L51.9
 ;;^UTILITY(U,$J,358.3,4731,2)
 ;;=^336759
 ;;^UTILITY(U,$J,358.3,4732,0)
 ;;=L12.35^^22^295^7
 ;;^UTILITY(U,$J,358.3,4732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4732,1,3,0)
 ;;=3^Epidermolysis Bullosa,Acquired
 ;;^UTILITY(U,$J,358.3,4732,1,4,0)
 ;;=4^L12.35
 ;;^UTILITY(U,$J,358.3,4732,2)
 ;;=^5009100
 ;;^UTILITY(U,$J,358.3,4733,0)
 ;;=L52.^^22^295^12
 ;;^UTILITY(U,$J,358.3,4733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4733,1,3,0)
 ;;=3^Erythema Nodosum
 ;;^UTILITY(U,$J,358.3,4733,1,4,0)
 ;;=4^L52.
 ;;^UTILITY(U,$J,358.3,4733,2)
 ;;=^42065
 ;;^UTILITY(U,$J,358.3,4734,0)
 ;;=L49.0^^22^295^24
 ;;^UTILITY(U,$J,358.3,4734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4734,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ < 10% Body Surface
 ;;^UTILITY(U,$J,358.3,4734,1,4,0)
 ;;=4^L49.0
 ;;^UTILITY(U,$J,358.3,4734,2)
 ;;=^5009190
 ;;^UTILITY(U,$J,358.3,4735,0)
 ;;=L49.1^^22^295^15
 ;;^UTILITY(U,$J,358.3,4735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4735,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 10-19% Body Surface
 ;;^UTILITY(U,$J,358.3,4735,1,4,0)
 ;;=4^L49.1
 ;;^UTILITY(U,$J,358.3,4735,2)
 ;;=^5009191
 ;;^UTILITY(U,$J,358.3,4736,0)
 ;;=L49.2^^22^295^16
 ;;^UTILITY(U,$J,358.3,4736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4736,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 20-29% Body Surface
 ;;^UTILITY(U,$J,358.3,4736,1,4,0)
 ;;=4^L49.2
 ;;^UTILITY(U,$J,358.3,4736,2)
 ;;=^5009192
 ;;^UTILITY(U,$J,358.3,4737,0)
 ;;=L49.3^^22^295^17
 ;;^UTILITY(U,$J,358.3,4737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4737,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 30-39% Body Surface
 ;;^UTILITY(U,$J,358.3,4737,1,4,0)
 ;;=4^L49.3
 ;;^UTILITY(U,$J,358.3,4737,2)
 ;;=^5009193
 ;;^UTILITY(U,$J,358.3,4738,0)
 ;;=L49.4^^22^295^18
 ;;^UTILITY(U,$J,358.3,4738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4738,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 40-49% Body Surface
 ;;^UTILITY(U,$J,358.3,4738,1,4,0)
 ;;=4^L49.4
 ;;^UTILITY(U,$J,358.3,4738,2)
 ;;=^5009194
 ;;^UTILITY(U,$J,358.3,4739,0)
 ;;=L49.5^^22^295^19
 ;;^UTILITY(U,$J,358.3,4739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4739,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 50-59% Body Surface
 ;;^UTILITY(U,$J,358.3,4739,1,4,0)
 ;;=4^L49.5
 ;;^UTILITY(U,$J,358.3,4739,2)
 ;;=^5009195
 ;;^UTILITY(U,$J,358.3,4740,0)
 ;;=L49.6^^22^295^20
 ;;^UTILITY(U,$J,358.3,4740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4740,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 60-69% Body Surface
 ;;^UTILITY(U,$J,358.3,4740,1,4,0)
 ;;=4^L49.6
 ;;^UTILITY(U,$J,358.3,4740,2)
 ;;=^5009196
 ;;^UTILITY(U,$J,358.3,4741,0)
 ;;=L49.7^^22^295^21
 ;;^UTILITY(U,$J,358.3,4741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4741,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 70-79% Body Surface
 ;;^UTILITY(U,$J,358.3,4741,1,4,0)
 ;;=4^L49.7
 ;;^UTILITY(U,$J,358.3,4741,2)
 ;;=^5009197
 ;;^UTILITY(U,$J,358.3,4742,0)
 ;;=L49.8^^22^295^22
 ;;^UTILITY(U,$J,358.3,4742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4742,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 80-89% Body Surface
 ;;^UTILITY(U,$J,358.3,4742,1,4,0)
 ;;=4^L49.8
 ;;^UTILITY(U,$J,358.3,4742,2)
 ;;=^5009198
 ;;^UTILITY(U,$J,358.3,4743,0)
 ;;=L49.9^^22^295^25
 ;;^UTILITY(U,$J,358.3,4743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4743,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ > 89% Body Surface
 ;;^UTILITY(U,$J,358.3,4743,1,4,0)
 ;;=4^L49.9
 ;;^UTILITY(U,$J,358.3,4743,2)
 ;;=^5009199
 ;;^UTILITY(U,$J,358.3,4744,0)
 ;;=Z65.5^^22^295^26
 ;;^UTILITY(U,$J,358.3,4744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4744,1,3,0)
 ;;=3^Exposure to Disaster/War/Hostilities
 ;;^UTILITY(U,$J,358.3,4744,1,4,0)
 ;;=4^Z65.5
 ;;^UTILITY(U,$J,358.3,4744,2)
 ;;=^5063184
 ;;^UTILITY(U,$J,358.3,4745,0)
 ;;=Z77.22^^22^295^27
 ;;^UTILITY(U,$J,358.3,4745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4745,1,3,0)
 ;;=3^Exposure to/Contact w/ Environmental Tobacco Smoke
 ;;^UTILITY(U,$J,358.3,4745,1,4,0)
 ;;=4^Z77.22
 ;;^UTILITY(U,$J,358.3,4745,2)
 ;;=^5063324
